Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

People with stroke can take common medicines without raising risk of another stroke

People with stroke can take common medicines without raising risk of another stroke

Scientists solve mystery surrounding mechanical forces that influence blood clotting

Scientists solve mystery surrounding mechanical forces that influence blood clotting

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study indicates the benefits of stopping aspirin in heart attack patients

Study indicates the benefits of stopping aspirin in heart attack patients

Access to real-time genotype data influences prescriber behavior after PCI

Access to real-time genotype data influences prescriber behavior after PCI

Combination treatment lowers risk of ischemic stroke recurrence

Combination treatment lowers risk of ischemic stroke recurrence

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Experimental vaccine shows promise to protect stroke survivors from blood clots

Experimental vaccine shows promise to protect stroke survivors from blood clots

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Clot busting drug combo reduces risk of major strokes in high risk patients

Clot busting drug combo reduces risk of major strokes in high risk patients

Drug combination may prevent secondary stroke in certain patients, study shows

Drug combination may prevent secondary stroke in certain patients, study shows

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Genetic testing could help guide blood-thinner treatment after stent placement

Genetic testing could help guide blood-thinner treatment after stent placement

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Two anticlotting medicines better at reducing bleeding risk than triple therapy

Two anticlotting medicines better at reducing bleeding risk than triple therapy

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease